34. Hamberg, M., and Samuelsson, B. (1967) J. Biol. Chem. 242, 5329 –5335
35. Chiang, N., Gronert, K., Clish, C. B., O'Brien, J. A., Freeman, M. W., and 48.
Serhan, C. N. (1999) J. Clin. Invest. 104, 309 –316
36. Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 49.
285, 252–261
37. Moore, M. A. S. (1999) N. Engl. J. Med. 341, 605– 607 50.
38. Serhan, C. N., Fierro, I. M., Chiang, N., and Pouliot, M. (2001) J. Immunol. 51.
166, 3650 –3654
39. Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., and Serhan, C. N. (2001) 52.
Nature Immunol. 2, 612– 619
40. Yergey, J. A., Kim, H.-Y., and Salem, N., Jr. (1986) Anal. Chem. 58, 1344 –1348 53.
41. Lee, T. H., Mencia-Huerta, J.-M., Shih, C., Corey, E. J., Lewis, R. A., and
Austen, K. F. (1984) J. Clin. Invest. 74, 1922–1933 54.
42. Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S.
(1990) in Biological Oxidation Systems Vol. 2, pp. 765–778, Academic Press 55.
43. Yokomizo, T., Ogawa, Y., Uozumi, N., Kume, K., Izumi, T., and Shimizu, T.
(1996) J. Biol. Chem. 271, 2844 –2850 56.
44. Vane, J. R., and Botting, R. M. (eds) (2001) Therapeutic Roles of Selective
COX-2 Inhibitors, William Harvey Press, London
45. Cla` ria, J., and Serhan, C. N. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 57.
9475–9479 58.
46. Wallace, J. L., Chapman, K., and McKnight, W. (1999) Br. J. Pharmacol. 126,
1200 –1204 59.
McConnell, H. M., Owicki, J. C., Parce, J. W., Miller, D. L., Baxter, G. T.,
